No profile data available.
Theriva Biologics, Inc. (TOVX) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in Rockville, United States, with about 15 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$25.25 million. Its market capitalization was $9.96 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a clinical-stage company, develops therapeutics to treat cancer and related diseases in areas of high unmet need in the United States.
Theriva Biologics reported $0 in revenue for fiscal year 2025.
$9.96 million as of October 9, 2026.
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include GT Biopharma, Inc. (GTBP), Aspire Biopharma Holdings, Inc. (ASBP), Aptorum Group Limited (APM), Senti Biosciences, Inc. (SNTI).